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The interactions of the antimicrobial peptides aurein 1.2, citropin 1.1 and maculatin 1.1 with dimyristoylphosphatidylcholine (DMPC),
dimyristoylphosphatidylglycerol (DMPG) and dimyristoylphosphatidylethanolamine (DMPE) were studied by differential scanning calorimetry
(DSC) and Fourier-transform infrared (FTIR) spectroscopy. The effects of these peptides on the thermotropic phase behavior of DMPC and
DMPG are qualitatively similar and manifested by the suppression of the pretransition, and by peptide concentration-dependent decreases in the
temperature, cooperativity and enthalpy of the gel/liquid–crystalline phase transition. However, at all peptide concentrations, anionic DMPG
bilayers are more strongly perturbed than zwitterionic DMPC bilayers, consistent with membrane surface charge being an important aspect of the
interactions of these peptides with phospholipids. However, at all peptide concentrations, the perturbation of the thermotropic phase behavior of
zwitterionic DMPE bilayers is weak and discernable only when samples are exposed to high temperatures. FTIR spectroscopy indicates that these
peptides are unstructured in aqueous solution and that they fold into α-helices when incorporated into lipid membranes. All three peptides undergo
rapid and extensive H–D exchange when incorporated into D2O-hydrated phospholipid bilayers, suggesting that they are located in solvent-
accessible environments, most probably in the polar/apolar interfacial regions of phospholipid bilayers. The perturbation of model lipid membranes
by these peptides decreases in magnitude in the order maculatin 1.1Naurein 1.2Ncitropin 1.1, whereas the capacity to inhibit Acholeplasma laidlawii
B growth decreases in the order maculatin 1.1Naurein 1.2≅citropin 1.1. The higher efficacy of maculatin 1.1 in disrupting model and biological
membranes can be rationalized by its larger size and higher net charge. However, despite its smaller size and lower net charge, aurein 1.2 is more
disruptive of model lipid membranes than citropin 1.1 and exhibits comparable antimicrobial activity, probably because aurein 1.2 has a higher
propensity for partitioning into phospholipid membranes.
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2-oleoyl phosphatidylglycerol; DMPC, dimyristoylphosphatidylcholine; DMPG, dimyristoylphosphatidylglycerol; DMPE, dimyristoylphosphatidylethanolamine;
DOPE, dioleoylphosphatidylethanolamine; DOPG, dioleoylphosphatidylglycerol; HPLC, high performance liquid chromatography; MLV, multilamellar vesicles;
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Amphibians are known to produce a number of host defense
peptides which are active against a variety of microbial patho-
gens [1] and the skin secretions of Australian tree frogs are rich
in such antimicrobial peptides (AMPs)1 [2]. The aureins,
citropins and maculatins are three families of structurally related
AMPs found in the skin secretions of several species of the
Australian tree frogs of the genus Litoria. [3–6]. Most of these
peptides exhibit antibacterial activity against both Gram-
positive and Gram-negative bacteria [2], and many of them
also exhibit fungicidal and anticancer activity [3], specific
neuronal nitric oxide synthetase inhibitory activity [2], and the
capacity to inhibit infection by enveloped viruses such as HIV
[7]. These AMPs generally appear to kill their microbial target
cells primarily by binding to and destabilizing the lipid bilayers
of their cell membranes, a fact which provides the primary
impetus for studies of their interactions with lipid bilayer model
and biological membranes [8].
The three best-studied Australian tree frog AMPs are aurein
1.2, citropin 1.1 andmaculatin 1.1. Aurein 1.2 is a 13-amino acid
peptide (GLFDIIKKIAESF-NH2) produced by the Australian
green and golden bell frog Litoria aureus and by the related
Australian southern bell frog Litoria raniformis [3]. This peptide
is cationic at physiological pH with a net charge +1. The 16-
amino acid peptide citropin 1.1 (GLFDVIKKVASVIGGL-NH2)
is found in the skin secretions of the Australian tree frog Litoria
citropa [4,5]. This peptide is also cationic at physiological pH
but with a net charge of +2. Maculatin 1.1 (GLFGVLAK-
VAAHVVPAIAEHF-NH2) is produced by the Australian tree
frog Litoria genimaculata [5]. This peptide is also cationic but is
larger (21 amino acid residues) with a net charge of +3 at
physiological pH. Notwithstanding the differences in the
primary structures of these three tree frog AMPs, there are a
number of common structural features which appear to be
functionally important. Indeed, they are all C-amidated linear
polypeptides with charged N-termini composed of the sequence
Gly–Leu–Phe, and one or more cationic residues located 7–
8 residues from their N-termini, features which all appear to be
essential for the maximal expression of their antibacterial
activities [2]. In aqueous solution, these peptides adopt primarily
unstructured random coil conformations but readily fold into α-
helical structures in membrane-mimetic environments [3–5,9].
As illustrated in Fig. 1, they form amphipathic helices in which
the polar and charged amino acids are linearly clustered on one
face of the helix and the nonpolar amino acid residues clustered
on the other face. However, when bound to membranes or
dissolved in membrane-mimetic solvents, aurein 1.2 and
citropin 1.1 both fold into single continuous α-helical structures,
whereas the longer peptide maculatin 1.1 forms two distinct α-
helical segments [5,10,11] separated by a so-called flexible
hinge region [5]. The hinge region of maculatin 1.1 arises from
the helix-disrupting properties of the Pro-15 residue, the
presence of which is required for maximum antibacterial activity
[10,11].1 See abbreviations.Unlike several other families of helix-forming AMPS [see
12,13], there have been relatively few studies of the interactions
of these three Australian tree frog AMPs with lipid model
membranes (see [8]). Monolayer studies of citropin 1.1 and
maculatin 1.1 alone have established that both of these peptides
are surface active. Moreover, when peptide was introduced into
the aqueous subphase under monolayer films of the zwitterionic
phospholipid POPC, citropin 1.1 and maculatin 1.1 appeared to
form separate domains, whereas with films of the anionic
phospholipid POPG, the peptide and lipid seemed to form a
single phase, perhaps due to the favorable electrostatic
interactions between the cationic peptide and the anionic
POPG molecules [14]. Solid-state 2H and 31P-NMR studies
[15,16] with bilayers of the zwitterionic phospholipid DMPC
were also performed with each of these peptides, which were
found to decrease the order and increase the mobility of both the
DMPC polar headgroups and hydrocarbon chains. However, the
interactions of these peptides with DMPC bilayers seem largely
localized to the polar headgroup and glycerol backbone regions
of the host phospholipid molecules. Moreover, the bilayer
structure is preserved even at high peptide concentrations and
the peptide molecules themselves appear highly mobile.
However, other 31P-NMR spectroscopic studies have shown
that the incorporation of aurein 1.2 into mixed DOPE:DOPG
membranes may actually promote the formation of inverted
nonlamellar phases [9]. FTIR spectroscopic studies of the
interaction of maculatin 1.1 with DMPC and DMPG bilayers
showed a marked preference of this peptide for binding to the
anionic phospholipid, in that about 70% of the amino acid
residues underwent amide H–D exchange when added to DMPC
vesicles, whereas only 5% did so when added to DMPG vesicles
[17]. Finally, solid-state 31P-NMR spectroscopic studies of the
interactions of maculatin 1.1 with live Gram-positive bacteria
indicate that the bacterial membrane were lysed and the
phospholipid bilayers were converted to small, micelle-like
structures [18], in contrast to the NMR results with DMPC
model membranes discussed above [11,14].
DSC is a powerful, nonperturbing thermodynamic technique
which has proven very useful for studies of lipid–protein in-
teractions in model and biological membranes in general (see
[19–21]) and for the study of the interactions of AMPs with lipid
bilayer model membranes in particular (see [22,23]). In order to
study the interactions of the frog AMPs aurein 1.2, citropin 1.1
and maculatin 1.1 with various phospholipid bilayer mem-
branes, we have utilizedDSC to study the effect of these peptides
on the thermotropic phase behavior of the major phospholipid
classes of bacterial and animal cells. Specifically, we have
studied the effect of various concentrations of these three pep-
tides on the pretransition and main transition of zwitterionic
DMPC and anionic DMPG, and on the main phase transition of
zwitterionic DMPE bilayer membranes. Since PCs are virtually
absent in bacterial membranes but are generally the most
abundant phospholipid class in eukaryotic plasma membranes,
DMPC bilayers can serve as a model for the surface membrane
of the cells of higher animals, especially as PCs are typically
localized primarily in the outer monolayer of the lipid bilayer of
such membranes. Similarly, PGs are absent from eukaryotic
Fig. 1. Molecular models of the structures expected of aurein 1.2, citropin 1.1 and maculatin 1.1 bound to lipid membranes. The coordinates used to draw these models
were obtained from previously published NMR-determined solution structures of these peptides in membrane-mimetic media [4,5,9].
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prokaryotic surface membranes. Moreover, PEs are major con-
stituents of all eukaryotic plasma membranes and are also
abundant in most Gram-positive bacteria and in members of the
Gram-positive Bacillus bacteria as well, although PEs are usu-
ally enriched in the inner monolayer of the lipid bilayer of
eukaryotic plasma membranes. Thus DMPE bilayers can serve
as a relevant model for the lipid bilayers of both animal and
bacterial membranes. We have also utilized FTIR spectroscopy
to study the conformation of these antimicrobial peptides as dry
films or when dissolved in aqueous buffer, as well as when
bound to DMPC, DMPE and DMPG bilayers in the gel and
liquid–crystalline phases, and to investigate the effect of these
peptides on the organization of the host phospholipid bilayer.
The results of these studies were correlated with the intrinsic
capacities of these peptides to disrupt the lipid bilayer of a cell
membrane as assayed by their capacity to inhibit the growth of
the cell wall-less mollicute Acholeplasma laidlawii B.
2. Materials and methods
DMPC, DMPE and DMPG were purchased from Avanti Polar Lipids
(Alabaster, AL, USA) and were used without further purification. Aurein 1.2,
citropin 1.1 and maculatin 1.1 were chemically synthesized (Mimotopes,
Melbourne, Australia and the Alberta Peptide Institute, Edmonton, Alberta,
Canada) by solid-phase techniques using Fmoc chemistry, and were shown to be
N95% pure by HPLC and mass spectrometry [24,25].
Samples were prepared for DSC as follows. Lipid and peptide were codis-
solved in methanol to attain the desired lipid-to-peptide ratio and the solvent was
removed with a stream of nitrogen, leaving a thin film on the sides of a clean glass
test tube. This filmwas subsequently dried in vacuo overnight to ensure removal of
the last traces of solvent. Samples containing∼1.0 mg of lipid were then hydrated
by placing somewet cottonwool into the tube (without contacting the lipid/peptide
film) and allowing the sample to absorb water from the water vapour-saturated airby warming the sample to temperatures well above the expected gel/liquid–
crystalline phase transition temperature of the lipid [26]. Subsequently, the cotton
wool was removed and the hydrated sample quickly dispersed by vigorous
vortexing with a known volume (typically 0.5–2.0 ml) of a prewarmed buffer
composed of 50 mM Tris, 150 mM NaCl, 1 mM NaN3, pH 7.4, at temperatures
some 10–15 °C above the lipid gel/liquid–crystalline phase transition temperature.
The variation in the dispersal volume utilized was done primarily to increase the
sample size of the peptide-rich samples so that the broader thermograms exhibited
by these samples could be more accurately recorded. DSC thermograms were
obtained from 0.324 ml samples with a high-sensitivity Nano DSC instrument
(Calorimetry Sciences Corporation, Lindon, UT, USA) operating at heating and
cooling rates of 10 °C/h. The data were analyzed and plotted with the Origin
software package (OriginLab Corporation, Northampton, MA, USA). In cases
where the DSC thermograms appeared to be a summation of overlapping
components, the midpoint temperatures, areas and widths of the components were
estimated with Origin nonlinear least squares curve- and peak-fitting procedures,
and a custom-coded function based on the assumption that the observed
thermogramwas a linear combination of components, each of which approximates
a reversible, two-state transition at thermodynamic equilibrium.
FTIR spectroscopy was performed on dried films and on aqueous solutions
of these frog AMPs, and on fully hydrated peptide–lipid dispersions. Typically,
dried films of the peptide were cast from methanolic solution onto a solid
support, typically one of the CaF2 windows of the demountable liquid cell
described below, followed by removal of the solvent. The hydrated peptide and
lipid:peptide samples were prepared for FTIR spectroscopy by dissolving the
peptide or by co-dissolving lipid and peptide in methanol at a lipid-to-peptide
ratio of 30:1 (mol/mol). After removal of the solvent and drying of the film,
samples containing peptide, or peptide and 2–3 mg of lipid, were hydrated by
vigorous mixing with 75 μL of a D2O-based buffer (50 mM Tris, 150 mMNaCl,
1 mM NaN3, pH 7.4). The dispersion obtained was then squeezed between the
CaF2 windows of a heatable, demountable liquid cell (NSG Precision Cells,
Farmingdale, NY) equipped with a 25-μm Teflon spacer. Once mounted in the
sample holder of the spectrometer, the sample temperature could be varied
between 0 and 90 °C by an external, computer-controlled water bath. FTIR
spectra were acquired as a function of temperature with a Digilab FTS-40
Fourier-transform spectrometer (Bio-Rad, Digilab Division, Cambridge, MA,
USA) using data acquisition parameters similar to those described by Mantsch
et al. [27]. With hydrated lipid:peptide mixtures, the experiment typically
Fig. 3. Illustration of the resolvable components found in the DSC thermograms
exhibited by lipid bilayers composed of peptide-poor (A) and peptide-rich
(B) mixtures of aurein 1.2, citropin 1.1 and maculatin 1 with DMPC and DMPG.
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inter-ramp delay for thermal equilibration, and was equivalent to a scanning rate
of 4 °C/h. Spectra were analyzed with software supplied by the instrument
manufacturers and computer programs obtained from the National Research
Council of Canada.
The cell wall-less mollicute A. laidlawii B was cultured in chloroform-
extracted BSA-free media and cell growth was monitored turbidometrically [28].
The effect of these antimicrobial peptides on cell growth was monitored as a
function of time and peptide concentration after the addition these peptides to the
culture medium just prior to a 10% (by volume) inoculation with cells in the mid-
log phase of growth. Cell growth was examined in media containing up to 10 μM
peptide and is expressed relative to the maximum growth obtained in the absence
of peptide. Where feasible, the growth inhibitory properties of the peptides were
expressed in terms of apparent LD50 values as described previously [29].
3. Results
3.1. Differential scanning calorimetry
DSC heating thermograms, illustrating the effect of the in-
corporation of increasing quantities of the peptides aurein 1.2,
citropin 1.1 and maculatin 1.1 on the thermotropic phase be-
havior of MLVs composed of the lower melting zwitterionic
phospholipid DMPC, are presented in Fig. 2. In the absence of
peptide, DMPC MLVs which have not been extensively
annealed at lower temperatures exhibit two endothermic events
on heating, a weakly energetic pretransition near 14 °C and a
strongly energetic main phase transition near 24 °C. The pre-
transition arises from the conversion of a lamellar gel phase with
tilted hydrocarbon chains (the Lβ′ phase) to a rippled gel phase
also with tilted hydrocarbon chains (the Pβ′ phase), while the
main or hydrocarbon chain-melting phase transition arises from
the conversion of the Pβ′ to the lamellar liquid–crystalline (Lα)
phase. The reader is referred to Lewis et al. [30] for a more
detailed description of the thermotropic phase behavior of
MLVs of DMPC and of other members of the homologous
series of linear saturated PCs. Note that the cooling exothermsFig. 2. DSC heating thermograms illustrating the effects of aurein 1.2 (A),
citropin 1.1 (B) and maculatin 1.1 (C) on the thermotropic phase behavior of
aqueous dispersions of DMPC. The thermograms shown were normalized for
lipid sample mass and were acquired at the peptide concentrations (mol%)
indicated on the left of each thermogram. The labels to the left of each
thermogram indicate the relative Y-scaling factors used for plotting.observed with DMPC and with its mixtures with all three
peptides (not shown here) exhibit near mirror image symmetry
relative to the heating endotherms, indicating that the major
thermotropic events were recorded under conditions very close
to thermodynamic equilibrium.
As illustrated in Fig. 2, the incorporation of these peptides
into DMPC MLVs significantly alters their thermotropic phase
behavior. Specifically, the presence of small amounts of these
peptides (DMPC:peptide ratio 200:1) reduces the temperature
and enthalpy of the pretransition and abolishes the pretransition
entirely at higher peptide concentrations. Moreover, small
quantities of these peptides initially induce a two-component
main phase transition, composed of a lower temperature, more
cooperative endotherm superimposed over a higher tempera-
ture, less cooperative (broader) endotherm (see Fig. 3A). As
peptide concentration increases, the temperature, (Fig. 4A),
enthalpy (Fig. 4B) and cooperativity of the sharp component all
decrease, whereas the temperature and enthalpy of the broad
component initially increase slightly, (Fig. 4B). Further
increases in peptide concentration also result in the progressive
decline and eventual elimination of the sharp component and
the formation of a third, lower temperature broad component
(see Fig. 3B) which grows progressively in intensity with
increasing peptide concentration (see Fig. 4B). Finally, with all
of these peptides, the total enthalpy of the main phase transition
(the sum of the areas of all endothermic components) initially
decreases fairly rapidly with increasing peptide concentration
and then declines less rapidly at higher peptide concentrations
(see Fig. 5). In analogy to our previous DSC studies of binary
mixtures of α-helical transmembrane peptides [31,32] and of
the AMP gramicidin S [22] with various phospholipids, we
assign the sharp and broad components of the DSC endotherm
to the chain-melting phase transition of peptide-poor and
peptide-rich phospholipid domains, respectively. This interpre-
tation of these DSC results is supported our FTIR spectroscopic
studies (see below).
Fig. 4. Illustration of the general effect of peptide concentration on the
temperature (A) and enthalpy (B) of the components resolved in the DSC
thermograms exhibited by mixtures of the aurein 1.2, citropin 1.1 and maculatin
1.1 with DMPC and DMPG. The datasets shown were derived from the ther-
mograms exhibited by aurein 1.2-containing DMPC mixtures, and represent the
properties of the sharp component of DSC thermogram (–♦–), the higher-
temperature broad component initially observed at low-peptide concentrations
(–■–), and the lower-temperature broad component observed at very high
peptide concentrations (–▾–).
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thermotropic phase behavior of DMPC MLVs are qualitatively
similar, close inspection of the data indicates the effects of each
peptide differ markedly in magnitude. With the citropin 1.1-
containing MLVs, the sharp component of the DSC thermogram
persists to higher peptide concentrations than observed with
aurein 1.2 and maculatin 1.1, and the peptide concentration-
induced diminution in its temperature and enthalpy is smaller
than observed with the latter two peptides (Fig. 5). Also, at
comparable peptide concentrations, the broad components
observed in the citropin 1.1-containing preparations are not as
prominent as those observed in the corresponding aurein 1.2-
and maculatin 1.1-containing MLVs (Fig. 2), and the peptide-Fig. 5. Effect of peptide concentration on the properties of the DSC thermograms
exhibited by mixtures of DMPC with aurein 1.2 (–♦–), citropin 1.1 (–■–) and
maculatin 1.1 (–▾–). The data shown illustrate the effects of peptide concen-
tration on (A) the transition temperatures of the sharp components in the DSC
thermograms, (B) the total enthalpy of all of the components resolved.induced decline in the overall transition enthalpy is less
pronounced than occurs with the other those peptides (Fig.
5B). In contrast, maculatin 1.1 produces a greater reduction in
the temperature (Fig. 5A), enthalpy (Fig. 5B) and cooperativity
of the sharp component, which is abolished at lower peptide
concentrations, and the reduction in the overall enthalpy of the
phase transition (Fig. 5) is greater than observed with either
aurein 1.2 or citropin 1.1. Thus, at comparable peptide
concentrations, the relative magnitude of the perturbation of
the thermotropic phase behavior of DMPC MLVs decreases in
the order maculatin 1.1Naurein 1.2Ncitropin 1.1.
DSC heating scans illustrating the effect of aurein 1.2,
citropin 1.1 and maculatin 1.1 on the thermotropic phase be-
havior of DMPG MLVs are presented in Fig. 6. As observed
with DMPC, the main cooling exotherms exhibited by pure
lipid and by its mixtures with all three peptides (not shown here)
also exhibit near mirror image symmetry relative to the baseline,
indicating that the major thermotropic events were recorded
under conditions approaching thermodynamic equilibrium.
Aqueous dispersions of DMPG which have not been exten-
sively annealed at low temperatures, also exhibit a weakly
energetic transition near 12 °C and a more energetic phase
transition near 24 °C. As with DMPC bilayers, the pretransition
arises from the conversion of the Lβ′ gel to the Pβ′ gel phase and
the main transition or chain-melting phase transition from the
conversion of the Pβ′ to the Lα phase. A subtransition is not
observed under these conditions since these DMPGMLVs were
not annealed at low temperatures. For a more detailed dis-
cussion of the thermotropic phase behavior of DMPG and other
members of the homologous series of linear saturated PGs, see
Zhang et al. [33].
It is clear that these peptides have a major effect on their
thermotropic phase behavior of DMPG MLVs, and that there
are a number of qualitative similarities between their effects
on DMPC and DMPG bilayers (see Figs. 2 and 6). Thus, asFig. 6. DSC heating thermograms illustrating the effects of aurein 1.2 (A),
citropin 1.1 (B) and maculatin 1.1 (C) on the thermotropic phase behavior of
aqueous dispersions of DMPG. The data shown were normalized for lipid
sample mass and acquired at the peptide concentrations (mol%) indicated on the
left of each thermogram. The labels to the left of each thermogram indicate the
relative Y-scaling factors used for plotting.
Fig. 8. DSC heating (A) and cooling (B) thermograms illustrating the effects of
aurein 1.2 on the thermotropic phase behavior of aqueous dispersions of DMPE.
The thermograms shown were acquired at the peptide concentrations (mol%)
indicated, normalized for lipid sample mass and plotted on the same scale.
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these peptides completely abolishes the pretransition of DMPG
dispersions. Moreover, the presence of increasing quantities of
these peptides initially induces a two-component main phase
transition, consisting of a lower temperature, more cooperative
endotherm superimposed over a high temperature, less cooper-
ative endotherm. The temperature (Fig. 7A), enthalpy (Fig. 7B)
and cooperativity of the sharp component again decrease as
peptide concentration increases, while the temperature of the
broad component increases slightly but its enthalpy and coop-
erativity decrease considerably. At higher peptide concentra-
tions, very broad, multicomponent DSC endotherms are also
observed and the total enthalpy of the main phase transition (the
sum of all the components observed) initially decreases
markedly and then declines less rapidly as peptide concentra-
tions increase. Notwithstanding these overall similarities,
however, a comparison of the data shown in Figs. 5 and 7
clearly indicates that with each of these cationic antimicrobial
peptides, the perturbation of the thermotropic phase behavior of
anionic DMPG bilayers is significantly greater than observed
with zwitterionic DMPC bilayers at comparable peptide
concentrations, underscoring the importance of membrane
surface charge in the interactions of these peptides with lipid
membranes.
Although there are qualitative similarities between the effects
of these three peptides on the thermotropic phase behavior of
DMPG, it is also clear that, as observed with DMPC, the effects
of each peptide differ substantially in magnitude. Thus, with the
citropin 1.1-containing DMPG mixtures, the midpoint temper-
ature of the sharp component of the DSC thermogram actually
initially increases slightly relative to pure DMPG and then
decreases with increasing peptide concentration (Fig. 7A).
However, the peptide-induced decrease in the temperature
(Fig. 7A), cooperativity and enthalpy (Fig. 7B) of this com-
ponent is less than observed with either aurein 1.2 and maculatin
1.1, and, as observed with the DMPC system, the sharp com-Fig. 7. Effect of peptide concentration on the properties of the DSC thermograms
exhibited by mixtures of DMPG with aurein 1.2 (–♦–), citropin 1.1 (–■–) and
maculatin 1.1 (–▾–). The data shown illustrate the effects of peptide
concentration on (A) the transition temperatures of the sharp components in
the DSC thermograms, (B) the total enthalpy of all of the components resolved.ponent persists to higher concentrations than observed with the
other two peptides. With the citropin 1.1-containing DMPG
MLVs, broad, multi-component endotherms tend to predomi-
nate at higher peptide concentrations than observed with either
aurein 1.2 or maculatin 1.1 (see Fig. 6), and the broad, lower-
temperature endotherm which emerges at high peptide concen-
trations grows more rapidly as a function of peptide concentra-
tion than observed with either aurein 1.2 or maculatin 1.1 (see
Fig. 6).Most probably, this aspect of the behavior of citropin 1.1-
rich DMPG mixtures is reflected by the increase in their total
enthalpy observed at very high peptide concentrations (see
Fig. 7B). In contrast, the effect of maculatin 1.1 incorporation on
the thermotropic phase behavior of DMPGMLVs is much more
similar to that of aurein 1.2 (see Fig. 6). However, the decrease in
the temperature (Fig. 7A) and enthalpy of the sharp and broad
endothermic components, and of the total overall transition
enthalpy (Fig. 7B), is greater with maculatin 1.1, indicating that
it is more perturbing of the organization of DMPG bilayers than
aurein 1.2. Thus, as observed with DMPC bilayers, the extent of
perturbation of the organization of DMPG bilayers by the
incorporation of these peptides also decreases in the order
maculatin 1.1Naurein 1.2Ncitropin 1.1. The possible basis of
these observations are explored in Discussion.
DSC heating and cooling thermograms illustrating the effects
of aurein 1.2 on the thermotropic phase behavior of aqueous
dispersions of the zwitterionic phospholipid DMPE are
presented in Fig. 8. In the absence of peptide, DMPE MLVs
which have not been incubated extensively at low temperatures
exhibit a single, relatively energetic Lβ/Lα phase transition near
50 °C on heating (see [34] for a complete description of the
thermotropic phase behavior of DMPE and other members of the
homologous series of linear saturated PEs). Upon cooling,
DMPE exhibits an asymmetric multi-component exotherm, the
temperatures range of whichmay extend to some 2 °C below that
of the corresponding heating scan (Fig. 8B). This behavior
differs markedly from that observed with PC and PG bilayers
[34], but is commonly observed with PE bilayers and has been
Fig. 9. Amide 1 and C_O stretching regions of the infrared spectra exhibited by
(A) dry film of aurein 1.2 (cast from methanolic solution), (B) aurein 1.2
dissolved in D2O-based buffer, (C) dry film of DMPC:aurein 1.2 mixture (lipid:
peptide=30:1, film cast from methanolic solution), (D) D2O-hydrated DMPC:
aurein 1.2 mixture (lipid:peptide=30:1, T=4 °C), (E) D2O-hydrated DMPC:
aurein 1.2 mixture (lipid:peptide=30:1, T=50 °C). The peaks marked with the
asterisks arise from trifluoroacetate counterions which co-purify with the
peptide during the synthesis.
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crystalline state [35]. When aurein 1.2 is incorporated into
DMPE vesicles, essentially no effect on the heating endotherms
of the gel/liquid–crystalline phase transition is observed, even at
high peptide concentrations (Fig. 8A). However, if these MLVs
are heated to temperatures well above their gel/liquid–
crystalline phase transition temperature, then increasing quan-
tities of peptide modestly reduce the temperature, enthalpy and
cooperativity and change the multicomponent structure of the
main phase transition upon subsequent cooling (Fig. 8B).
Similar results were observed with citropin 1.1 and maculatin
1.1 (data not presented), and as with DMPC and DMPG MLVs,
the relative perturbation of the thermotropic phase behavior of
DMPE MLVs, although modest, also decreased in the general
order maculatin 1.1Naurein 1.2Ncitropin 1.1. These findings
indicate that the presence of any of these three peptides produces
a much smaller reorganization of DMPE than of DMPC and
especially DMPG bilayers, even after maximizing peptide–
DMPE interactions by exposure to high temperatures and by
multiple cycling through the gel/liquid–crystalline phase
transition. The fact that significant peptide-induced perturbation
of the thermotropic behavior of this lipid is observed only after
samples are heated to temperatures well above the gel/liquid–
crystalline phase transition temperature of the lipid implies that
interactions of these peptides with DMPE can be initiated only in
rather fluid bilayers. In marked contrast to DMPE MLVs,
peptide interactions with DMPC and DMPG MLVs can be
initiated at temperatures near to or even below that of the lipid
gel/liquid–crystalline phase transition (see Figs. 2 and 7).
3.2. Fourier-transform infrared spectroscopy
FTIR spectroscopy was used to monitor the conformation of
these antimicrobial peptides in the dry state, when dissolved in
water, and when bound to phospholipid bilayers, and also to
study the effects of these peptides on the thermotropic phase
behavior and organization of the host lipid membrane.
Specifically, information about the conformation of these
peptides can be obtained from the frequencies of the amide I
and amide II absorption bands, which arise predominantly from
the stretching vibrations of the amide carbonyl groups and the
N–H bending vibrations of the amide protons, respectively [36].
Also, because of its sensitivity to amide H–D exchange, the
intensity of the amide II band can be used to study the
exchangeability of the peptide amide backbone protons and thus
to provide information about the overall accessibility of the
peptide amide backbone to the solvent [37,38]. Finally, the
physical state and organization of the phospholipid bilayer can
be evaluated by an examination of the CH2 stretching bands,
which are sensitive to the degree of rotational isomeric disorder
of the lipid hydrocarbon chains, the ester carbonyl stretching
band, which is sensitive to the degree of hydration and hydrogen
bonding interactions in the membrane polar/apolar interfacial
region, and the O–P–O asymmetric stretching band, which is
also sensitive to the polarity and degree of hydration of the
phosphate moiety of the phospholipid polar headgroup [39,40].
However, in these studies, the presence of these frog peptidesdoes not seem to produce significant changes in the hydration or
polarity of either the phospholipid carbonyl or phosphate
groups. Thus, the only spectroscopic features presented in detail
here are the amide I and II bands of the peptides and the CH2
symmetric stretching band of the phospholipid hydrocarbon
chains.
Illustrated in Fig. 9 are the amide I and C_O stretching
regions of the FTIR spectra exhibited by methanol-dried and
D2O-hydrated samples of aurein 1.2 in the presence and absence
of DMPC (DMPC/peptide molar ratio 30:1, corresponding to a
peptide concentration of 3.3 mol%). The data shown therein are
similar to those obtained with samples of citropin 1.1 and
maculatin 1.1 under comparable conditions. When cast from
methanolic solution, all three peptides exhibit relatively sharp
amide I bands with maxima near 1658–1660 cm−1 and amide II
bands centered near 1540–1543 cm−1 (see Fig. 9A). The
properties of these bands are consistent with the predominance
of α-helical peptide conformations under such conditions [36].
Upon hydration of these films with D2O-based buffers, these
peptides all exhibit broad, low-intensity amide I band contours
centered near 1640–1660 cm−1 (see Fig. 9B), consistent with
these peptides being predominantly unstructured in aqueous
solution [36]. Also, the amide II band is completely abolished
under such conditions (see Fig. 9B), as would be expected of a
very flexible peptide in which all exchangeable amide protons
can be readily exchanged. Fig. 9C also shows that dry, peptide-
containing lipid films cast from methanolic solution exhibit
sharp amide I and amide II bands with maxima near 1658–
1660 cm−1 and 1540–1543 cm−1, respectively, along with an
absorption band near 1735 cm−1 arising from the stretching
vibrations of the lipid ester carbonyl groups. However, the
amide I and amide II bands observed in the lipid–peptide films
are narrower than those observed with the lipid-free peptide
films, consistent with the predominance of peptide α-helices
with a greater degree of homogeneity of peptide conformation
Fig. 10. Temperature-dependent changes in the frequency of the CH2 symmetric
stretching band observed in the FTIR spectra exhibited by peptide-free (–■–)
and peptide-containing (–□–) phospholipid bilayers. Data are presented for:
(A) DMPC:aurein 1.2 (30:1). (B) DMPG:aurein 1.2 (30:1). (C) DMPE:aurein
1.2 (30:1).
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of the lipid–peptide films with D2O-based buffer, some broad-
ening of the amide I band occurs, indicating that the mobility
and/or conformational flexibility of the lipid-associated peptide
increases upon hydration. However, the peptide amide I band
maxima also shift to frequencies near 1646–1650 cm−1 upon
addition of D2O and the amide II band is quickly (b5 min)
abolished (see Fig. 9D and E). Also, once the sample is fully
hydrated, the contours of the amide I band remain essentially
insensitive to changes in both temperature and the phase state of
the lipid (see Fig. 9D and E). This pattern of behavior is observed
with each peptide in all of the phospholipid systems examined.
The persistence of relatively sharp amide I bands, along with the
downward shift in the amide I band maxima and the
disappearance of the amide II band upon hydration with D2O,
are consistent with the predominance of lipid-associated α-
helical peptide structures for which complete H–D exchange of
backbone amide protons has occurred [36]. The fact that essen-
tially complete amide H–D readily occurs upon D2O hydration
of dry lipid–peptide films suggests that the lipid-associated
peptides are located in an environment which is accessible to the
solvent and/or in an environment conducive to a rapid exchange
between lipid-associated peptide α-helices and unstructured
peptide molecules in the bulk solvent phase. The latter
possibility is supported by the observed hydration-induced
broadening of the amide I band (see Fig. 9C–E). However, it
should be noted that the fast and extensive H–D exchange upon
D2O hydration of lipid:peptide films reported here differs
markedly from the results of previously published FTIR
spectroscopic studies, where only partial H–D exchange was
observed over a much longer time period (see [17]). Most
probably, the difference between the two sets of results reflects
the fact that this study was performed in excess liquid D2O
whereas the previous study was performed under conditions of
more limiting sample hydration.
The effect of the incorporation of these antimicrobial pep-
tides on the chain-melting phase transition and the organization
of the gel and liquid–crystalline states of the host phospholipid
bilayer was also probed by an examination of the frequency of
the hydrocarbon chain CH2 symmetric stretching band as a
function of temperature. As exemplified by our observations of
the peptide-free and aurein 1.2-containing DMPC, DMPE and
DMPG vesicles (see Fig. 10), the presence of each of these
antimicrobial peptides broadens the overall gel/liquid–crystal-
line phase transition of the host phospholipid bilayer, although
this broadening is much more pronounced in DMPC and
DMPG as compared to DMPE bilayers, in agreement with the
DSC results. Moreover, the incorporation of these peptides also
lowers the midpoint temperature of the DMPC and DMPG
vesicles, but not of the DMPE vesicles, again in agreement with
the DSC findings. From the upward shift in the CH2 symmetric
stretching band frequency, it also appears that the presence of
these peptides disorders the hydrocarbon chains slightly in the
gel phase and more markedly in the liquid–crystalline phases of
all the phospholipid vesicles studied, although this effect is
again more pronounced with DMPC and DMPG than with
DMPE bilayers. However, when the effects of the other peptideson the organization of DMPC and DMPG bilayers were com-
pared, maculatin 1.1 seemed to have the greatest effect in
disordering the gel phase than the either aurein 1.2 or citropin
1.1, although citropin 1.1 had the greatest disordering effect in
the liquid–crystalline state. However, in all cases the magnitude
of these hydrocarbon chain-disordering effects are relatively
small in the gel state, although considerably larger in the liquid–
crystalline state of DMPG and particularly of DMPC bilayer
membranes.
Finally, in order to examine the structural basis of some of
the broad thermotropic events observed in peptide-rich samples
of DMPC and DMPG, the frequencies of the peptide amide I
band and the lipid CH2 symmetric stretching band were plotted
as a function of temperature and overlaid on the DSC thermo-
grams exhibited by mixtures of all three peptides with these
phospholipids. The DMPG-based data presented in Fig. 11
typify our observations of both DMPC- and DMPG MLVs at
high concentrations of these peptides. As exemplified by the
data obtained in our studies of the citropin 1.1-rich DMPG
samples (see Fig. 11B), the frequency of the amide I bands of
these peptides changes very little with temperature, indicating
that the α-helical conformation of the peptide was little affected
by increases in temperature generally, or by the gel/liquid–
crystalline phase transition of the host phospholipid bilayer in
particular. Also, the peptide-broadened gel/liquid–crystalline
phase transition of the host phospholipid bilayer is clearly
shown by a more gradual, temperature-induced increase in the
frequency of the CH2 symmetric stretching frequency from
about 2850 cm−1, which is characteristic of the all-trans
hydrocarbon chains of gel state phospholipid bilayers, to about
2853 cm−1, which is characteristic of the gauche conformer-
Table 1
Antimicrobial activity and physicochemical parameters of the antimicrobial
peptides aurein 1.2, citropin 1.1 and maculatin 1.1
Peptide properties Aurein 1.2 Citropin 1.1 Maculatin 1.1
No. of amino acid residues 13 16 21
Molecular weight 1481 1682 2148
Net charge at neutral pH +1 +2 +3
A. laidlawii B growth inhibition:
apparent LD50 (μM)
2.31±0.22 2.25±0.18 1.22±0.15
A. laidlawii B growth inhibition:
MIC range (μM) a
2.5–5.0 2.5–5.0 2.5–5.0
Water to membrane interface
partitioning (unfolded) b
−0.38 −1.29 0.67
Water to membrane interface
partitioning (α-helical) b
−5.58 −7.69 −7.73 c
(−5.8 to −6.0)
Water to octanol partitioning b 11.91 10.78 12.11
Helical content (%) d 90–95 76–85 65–76
Helical hydrophobic moment b 6.77 4.1 6.8c (4.2)
a The lowest concentration range within which no growth is detected over a
period of 24 h. A MIC range of 2–4 μM indicates that growth is detected at
2 μM but not at 4 μM.
b Values (kcal/mol) calculated from the experimentally-determined
hydrophobicity scale of White and co-workers [55–57].
c Values assume that maculatin 1.1 can be completely α-helical in a lipid
membrane. More realistic estimates based on the solution structure of maculatin
1.1 in membrane-mimetic media [5] are given in brackets.
d Estimated from analyses of published NMR-determined solution structures
of these peptides [4,5,9] in membrane-mimetic solvents.
Fig. 11. Representative temperature-dependent changes in the frequencies of the
lipid CH2 symmetric stretching band (–■–) and the peptide amide I band (–▾–)
exhibited by peptide-rich samples of DMPC and DMPG. Data are presented for
(A) aurein 1.2 in DMPG (30:1), (B) citropin 1.1 in DMPG (30:1), (C) maculatin
1.1 in DMPG (30:1). The DSC heating thermograms exhibited by the samples
are shown by the solid line.
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lipid bilayers. Moreover, the temperature range of the phospho-
lipid hydrocarbon chain-melting phase transition as observed by
FTIR spectroscopy coincides closely with the higher temper-
ature components of the DSC thermogram, but not with the
broad, lowest temperature components (Fig. 11). These
observations indicate that neither peptide conformational
change nor hydrocarbon chain-melting are involved in the
broad lowest-temperature thermotropic event observed in the
DSC thermograms exhibited by citropin 1.1-rich mixtures of
these peptides with DMPG. However, this may not be true of
aurein 1.2- and maculatin 1.1-containing bilayers, where all of
the components of the DSC endotherms observed in DMPG
vesicles seem to be associated with melting of the phospholipid
hydrocarbon chains. Very similar results were observed when
each of these peptides were incorporated into DMPC MLVs
(data not presented). The nature of the lowest-temperature
endothermic event observed by DSC in citropin 1.1-containing
DMPC and DMPG vesicles is presently not understood and will
require additional study. However, the possibility of significant
peptide-induced formation of micelles, small unilamellar
vesicles or nonlamellar lipid phases at high peptide concentra-
tions can be eliminated, because 31P-NMR spectroscopic
studies performed by us [unpublished data] and others [15,16]
indicate that the bilayer structures of the DMPC and DMPG
vesicles are maintained even at the highest concentrations of the
three frog AMPs used in these studies.3.3. Inhibition of A. laidlawii B growth
The effects of aurein 1.2, citropin 1.1 and maculatin 1.1 on
the growth of A. laidlawii B, a cell wall-less Gram positive
bacterium (Mollicute), were also investigated in order to eval-
uate the relationship between the results of the physical mea-
surements described above and antimicrobial properties of these
peptides. A. laidlawii B is well suited for this type of work
because the composition, organization and dynamics of its
membrane lipid bilayer have been extensively studied [41,42],
and because the absence of a cell wall or outer membrane
should allow these peptides to interact directly with its cell
membrane lipid bilayer, the presumed primary target of this
class of AMPs (see [8]). It is generally found that the lipo-
polysaccharides in the cell wall or outer membrane of Gram-
negative bacteria and the lipopeptidoglycan outer layer of
Gram-positive bacteria may compete for the binding of AMPs
with the lipid bilayer of the inner membrane or physically
exclude such peptides from or otherwise impede their access to
the periplasmic space [43,44]. Our use of A. laidlawii B to assay
the antibiotic potencies of these peptides is thus intended to
circumvent such problems, so that a clearer relationship may be
established between the intrinsic capacities of these peptides to
disrupt cell membranes and the calorimetric and spectroscopic
data presented here.
The effects of the three peptides on the growth of A. laidlawii
B are summarized in Table 1. The growth inhibitory activities of
aurein 1.2 and citropin 1.1 against A. laidlawii B are clearly
comparable in magnitude, as evidenced by the similarities in
their apparent LD50 values (∼2.3 μM) and MIC ranges (2.5–
5 μM). However, the apparent LD50 value obtained for
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peptides, indicating that despite the similarities in the observed
MIC ranges of these peptides, maculatin is approximately twice
as effective at inhibiting A. laidlawii B growth. The fact that
maculatin 1.1 is more effective at disrupting cell membranes
than either aurein 1.2 or citropin 1.1 is consistent with our
biophysical data and previously published studies of the
interactions of these peptides with model lipid membranes
[14–16].
4. Discussion
An important finding of this work is that the magnitude of
the effect of the incorporation of the AMPs aurein 1.2, citropin
1.1 and maculatin 1.1 on the thermotropic phase behavior of
phospholipid MLVs depends on the structure as well as on the
net charge of the phospholipid polar headgroup. Specifically,
the incorporation of these peptides has little effect on the tem-
perature, enthalpy or cooperativity of the main phase transition
of zwitterionic DMPE bilayers, even after multiple cycling
through the gel/liquid–crystalline phase transition temperature.
Only after exposure to high temperatures is a small decrease in
the temperature, enthalpy and cooperativity of the main phase
transition of DMPE MLVs observed. In contrast, the incorpo-
ration of these three peptides into zwitterionic DMPC MLVs
produces much larger decreases in the temperature, enthalpy
and cooperativity of the main phase transition, as well as pro-
ducing multicomponent DSC endotherms, while their incor-
poration into anionic DMPGMLVs produces even larger effects
on overall thermotropic phase behavior. This underlying pattern
of behavior is essentially similar to that noted in similar DSC
studies of the interactions of the β-sheet cyclic AMP gramicidin
S [22] and several other α-helical AMPs with different phos-
pholipid bilayers (see [45,46]). The fact that the differences
between the effects of such peptides on the overall thermotropic
phase behavior of the zwitterionic phospholipids DMPE and
DMPC are actually larger than between the zwitterionic phos-
pholipid DMPC and the anionic phospholipid DMPG MLVs
also indicates that polar headgroup structure can be as important
as net polar headgroup charge in determining the strength of the
interaction of these peptides with the host phospholipid bilayer.
The observation that aurein 1.2, citropin 1.1 and maculatin
1.1 all interact more strongly with anionic DMPG bilayers than
with zwitterionic DMPC and DMPE bilayer is probably due in
part to the more favorable electrostatic interactions between
these cationic peptides and the negatively charged surfaces of
DMPG bilayers. It has been demonstrated that cationic drugs
[47] and AMPs [12,13] can disrupt the electrostatic interactions
between the positively charged choline (or ethanolamine)
moieties and the negatively charged phosphate groups of
adjacent phospholipid molecules. Electrostatic attraction be-
tween the positively charged residues of these tree frog AMPs
and the negatively charged phosphate moieties of the phosphor-
ylcholine and phosphorylethanolamine polar headgroups of
DMPC and DMPE is thus highly probable, but when compared
with negatively charged lipids such as DMPG, the overall
strength of such interaction will be markedly attenuated throughcompetition with the positively charged choline and ethanol-
amine moieties at the surfaces of DMPC and DMPE bilayers,
respectively. Moreover, the strength of such interactions will
probably be less pronounced with DMPC bilayers because of
steric shielding of the positively charged quaternary nitrogen of
the choline moiety by the three attached methyl groups. Because
of this, net electrostatic attraction between these peptides and
DMPC polar headgroups will probably be stronger than occurs
with DMPE bilayers, perhaps accounting in part for the stronger
interactions of these peptides with the DMPC as observed in the
present study. The idea that electrostatic interactions are an
important aspect of the antimicrobial activity and interactions of
these peptides with both anionic and zwitterionic bilayers is also
consistent with previously published monolayer [14] and in-
frared spectroscopic [17] studies of these three peptides. Indeed,
this seems to be a common feature of most cationic, membrane-
targeted AMPs and underscores the functional importance of the
positively charged residues of such peptides in vivo.
However, other differences between the physical properties
of DMPC as DMPE bilayers may also account for the apparently
stronger interactions of aurein 1.2, citropin 1.1 andmaculatin 1.1
with DMPC compared to DMPE vesicles. For example, these
peptides may interact preferentially with liquid–crystalline
DMPC rather than DMPE bilayers because of the greater
fluidity and decreased packing density of the former phospho-
lipid as compared to the latter (see [34,35]). This suggestion is
supported by our present findings that these peptides interact less
strongly with gel as compared to liquid–crystalline bilayers of
both of these zwitterionic phospholipids and more strongly with
DMPC than with DMPE at comparable reduced temperatures in
the liquid–crystalline state, and by our observation that
significant peptide–DMPE interactions are only observed after
exposure to high temperatures. It is also possible that the
capacity for hydrogen bond formation between these peptides
and the polar headgroup and interfacial regions of the host
phospholipid bilayer may also be important in determining the
strength and nature of peptide–phospholipid interactions.
Similar patterns of behavior were observed in comparable
studies of the interaction of the antimicrobial peptide gramicidin
S with the polar/apolar interfaces of lipid model membranes and
were ascribed to the increased penetration of the polar/apolar
interfaces of more disordered lipid bilayers [48]. Additional
studies on a wider variety of other lipids will be required to
elucidate the nature of these frog antimicrobial-peptide phos-
pholipid interactions in greater detail.
The comparative effects of the incorporation of the frog
antimicrobial peptides studied here on the thermotropic phase
behavior of zwitterionic and anionic phospholipid bilayers can
also be used to deduce both the general location of this peptide
relative to the lipid bilayer and the nature of the lipid–peptide
interactions involved. For example, Papahadjopoulos et al. [19]
and McElhaney [20] have proposed that many membrane-
associated proteins can be classified into one of three groups
with regard to their interactions with phospholipid bilayers.
Group I proteins are typically positively charged, water soluble,
peripheral membrane proteins that interact much more strongly
with anionic than with zwitterionic lipids. The interactions of
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increase both the temperature and enthalpy of the main phase
transition temperature while decreasing its cooperativity only
slightly. Group I proteins are localized on the bilayer surface
where they interact only with the phospholipid polar headgroups
primarily by electrostatic interactions. Group II proteins are also
typically positively charged at neutral pH but are somewhat less
water soluble and interact somewhat more strongly with anionic
than with zwitterionic phospholipid bilayers. The interactions of
these proteins with anionic and zwitterionic phospholipid
bilayers usually decrease the temperature, enthalpy and
cooperativity of the main phase transition moderately, at least
at relatively high protein concentrations. Group II proteins are
localized at the polar/nonpolar bilayer interface where they
interact primarily with the polar headgroups and glycerol
backbone region of the phospholipid molecules by both
electrostatic and hydrogen bonding interactions, although
some hydrophobic interactions with the region of the hydrocar-
bon chains near the bilayer interface also occurs. Finally, Group
III proteins have a range of charges but are water-insoluble,
integral membrane proteins that interact equally well with
anionic and zwitterionic phospholipid bilayers. The effect of the
incorporation of such proteins into phospholipid bilayers is
usually to reduce the temperature only slightly but to decrease
the enthalpy and cooperativity of the main phase transition
markedly. Group III proteins penetrate into or through
phospholipid bilayers and interact extensively with the phos-
pholipid hydrocarbon chains by hydrophobic and van derWaal's
interactions, as well as with the phospholipid polar headgroups
by electrostatic and hydrogen bonding interactions. The
incorporation of Group I proteins also usually has little effect
on the permeability of the anionic phospholipid vesicles with
which they interact, while the incorporation of Group II and
Group III proteins increases anionic, and zwitterionic and
anionic phospholipid vesicle permeability, respectively. We can
conclude from their chemical structures and physical properties,
as well as from their effects on the thermotropic phase behavior
and permeability of the zwitterionic and anionic phospholipid
vesicles, that the three frog AMPs studied here can be classified
as Group II proteins. Proteins in this group would thus be
expected to reside near the glycerol backbone region of the
phospholipid bilayer, with the polar and charged groups of their
amphiphilic helices interacting primarily with the polar head-
groups of the phospholipid molecules by electrostatic and
hydrogen bonding interactions, and with their nonpolar amino
acids interacting with the upper regions of the phospholipid
hydrocarbon chains via hydrophobic and van der Waal's forces.
The location of these peptides in the polar/apolar interfacial
regions of zwitterionic and anionic phospholipid bilayers is
consistent with the results of our present FTIR spectroscopic
studies and with the results of most of the previous studies
summarized in Introduction.
As expected, the relative magnitude of the perturbation of the
thermotropic phase behavior of each of the phospholipid MLVs
investigated here varies considerably with the structure of the
frog antimicrobial peptide. Specifically, the relative potencies of
these peptides in reducing the temperature, enthalpy and coop-erativity of the sharp component, and in altering the temperature
and reducing the enthalpy and cooperativity of the broad
component of the main phase transition, decrease in the order
maculatin 1.1Naurein 1.2Ncitropin 1.1 in both zwitterionic and
anionic phospholipid bilayers. These experimental observations
are generally compatible with data reported in some NMR
spectroscopic studies [16]. For some classes of antimicrobial
peptides, variations in their capacity for disrupting lipid bilayers
are strongly and positively correlated with variations in the size
of the peptide and the net charge carried on their polar surfaces
(for examples, see [49–52]). However, although both larger size
and greater surface charge may explain why maculatin 1.1 is
more disruptive of the structure and organization lipid bilayers
than either aurein 1.2 or citropin 1.1, they cannot explain why
aurein 1.2 is more effective at disrupting model membranes than
citropin 1.1, despite its being smaller than citropin 1.1 and
having a lower net charge on its polar surface. Thus, although
peptide size and charge are probably significant contributors to
the differential capacity of these peptides to perturb the thermo-
tropic phase behavior of phospholipid bilayer membranes, these
factors cannot fully explain our experimental findings.
Our data also show that antibiotic potencies of these peptides,
as determined by their capacity to inhibit A. laidlawii B growth,
can be ranked in the following order: maculatin 1.1Naurein
1.2≅citropin 1.1. This observation is largely compatible with
measurements of the relative capacities of these peptides to
permeabilize lipid vesicles [53]. The observation that the
antibiotic activity of maculatin 1.1 is higher than that of either
aurein 1.2 or citropin 1.1 is also compatible with many, though
not all, of the assays of the antibiotic activities reported for these
peptides (for examples, see [4–6,8]), and with the results of the
biophysical studies presented here and elsewhere (see [8,11,14–
18]). However, the differences between the antibiotic activities
of aurein 1.2 and citropin 1.1 as observed in this and other
studies [4–6,8] are not well correlated with our calorimetric data
and with other biophysical data reported in the literature [8,11,
14–18]. In principle, the higher antibiotic potency of maculatin
1.1 relative to both aurein 1.2 and citropin 1.1 can be rationalized
on the basis of its larger size and higher net surface charge.
However, as with the calorimetric data discussed above, such
considerations cannot explain the small differences between the
antibiotic potencies of aurein 1.2 and citropin 1.1 reported here,
nor the even wider variations in their relative antibiotic activities
that have been reported elsewhere (see [4–6,8]). However, the
antibiotic activities determined for membrane-targeted antimi-
crobial peptides such as these can be strongly influenced by the
presence and nature of the bacterial cell wall, which may also
influence access to the plasma membrane (see [43,44]), and by
the capacity of the organism to degrade the peptide by
proteolysis or other means (see [54]). Thus, a strict correlation
of in vivo assays of antimicrobial activity with the physiochem-
ical properties of AMPs, or with their biophysically-determined
propensities for the disruption of phospholipid model mem-
branes, may not always be observed. However, in these studies,
cell wall-related issues should not apply to A. laidlawii B, the
cell wall-less mollicute used to assay antimicrobial activity.
Also, because of the strong homology of the amino acid
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their susceptibility to proteolytic degradation under similar
conditions is probably unlikely. Consequently, an argument can
be made that there should be a better correlation between our
assayed antimicrobial activities of aurein 1.2 and citropin 1.1
and their capacity to disrupt lipid bilayers, as determined by the
biophysical studies reported here and elsewhere (see [8,11,14–
16]). Evidently, there are aspects to the biological activities of
these peptides that are not fully captured by biophysical studies
of their interactions with lipid model membranes.
Listed in Table 1 are estimates of some selected physico-
chemical parameters of aurein 1.2, citropin 1.1 and maculatin
1.1, along with the size and charge data alluded to above. The
parameters listed therein reveal a number of features which may
be relevant to the interpretation of the biological and biophysical
data available on these antimicrobial peptides. In particular, we
note that the helical hydrophobic moment calculated for aurein
1.2 is greater than that of citropin 1.1, and may even exceed that
of maculatin 1.1, once the latter is appropriately weighted for the
helix-destabilizing effect of its Pro-15 residue. This implies that
aurein 1.2 is inherently the most amphipathic of the three
peptides studied, and suggests that despite its smaller size, aurein
1.2 helices may have a stronger affinity for hydrophobic surfaces
and lipid membranes than those of citropin 1.1. This suggestion
is supported by studies showing that aurein 1.2 is more strongly
retained by reversed phase HPLC columns than citropin 1.1
(unpublished experiments from this laboratory). The large
positive values for the water-to-octanol partitioning free energies
(10–12 kcal/mol) also suggest that partitioning of all three
peptides into the hydrophobic domains of lipid membranes
should be highly unfavorable relative to their partitioning into
the aqueous phase. In contrast, the sizeable negative values (−5
to −8 kcal/mol) calculated for the transfer of α-helical con-
formers of these peptides into membrane polar/apolar interfaces
fromwater suggests that that process should be highly favorable,
although the same is not the case for the transfer of the un-
structured conformers of these peptides into membrane polar
apolar interfaces from water (partitioning free energies −0.4 to
−1.3 kcal/mol). In this respect, the calculated partitioning free
energies are consistent with the sizeable body of experimental
evidence indicating that these peptides have a high propensity
for partitioning into membrane polar/apolar interfaces as α-
helices [this work, 15,16]. Interestingly, the data shown also
suggest that the transfer of aurein 1.2 helices into membrane
interfaces (−5.8 kcal/mol) should be less favorable than the
corresponding transfer of citropin 1.1 and maculatin 1.1 helices
by ∼2 kcal/mol. However, these helix partitioning free energy
values are based on the assumption that the peptides are
completely helical when partitioned into the polar apolar inter-
faces of lipid membranes. NMR solution structure studies of
these peptides [3–5,9] indicate that although such an assumption
is tenable with aurein 1.2 and citropin 1.1, it cannot hold with
maculatin 1.1, mainly because of the helix disruption caused by
the Pro-15 residue. Thus, when weighted for the helix-disrupting
effects of the Pro-15 residue, the estimates of the free energy of
transferring maculatin 1.1 from water to membrane interfaces
become less favorable by about 1.8 to 2 kcal/mol (see Table 1).This observation illustrates clearly that the water-to-membrane
partitioning properties of peptides such as these are quite
sensitive to their overall α-helical-forming propensities, the
effects of which are not usually considered in studies such as
these.
We also note that aside from the differences in size, the major
significant differences between aurein 1.2 and citropin 1.1 are
the valine substitutions at Ile-5, Ile-9 and Ser-12 of aurein 1.2,
and a serine substitution at Glu-11. However, because of the
lower helix-forming propensity of valine (see [58,59]), and the
fact that the mean helix-forming propensity of the extension
GGL sequence at the C-terminus of citropin 1.1 is also
relatively low, α-helical structures formed by citropin 1.1 will
probably be less stable than those formed by aurein 1.2. Also,
the α-helices formed by aurein 1.2 will probably be further
stabilized by i+3 and i+4 salt bridge interactions between the
negatively charged Glu-11 side chains and the positively
charged amino side chains at Lys-7 and Lys-8, in marked
contrast to the citropin 1.1 α-helices, for which such interactions
are precluded by the Glu-11 to Ser-11 substitution. With macu-
latin 1.1, one can also argue that because of the combined helix-
destabilizing effects of its four valine residues and Pro-15
residue, along with the fact there is no potential for helix
stabilization by i+3 and i+4 ionic interactions between side
chains, this peptide will probably form α-helices that are less
stable than those formed by aurein 1.2 or possibly even citropin
1.1. Such arguments are supported by our analyses of previously
published NMR-determined solution structures of these peptides
in membrane-mimetic solvents (see [4,5,9]), which indicate that
the helical content of conformers formed under such conditions
differ significantly and decrease in the order aurein 1.2Ncitropin
1.1Nmaculatin 1.1 (see Table 1). We therefore suggest that
because of its higher α-helical-forming propensity and tendency
to fold into more stable α-helices, the partitioning of aurein 1.2
into the polar/apolar interfaces of lipid membranes will probably
be more favorable than suggested by the partitioning free energy
estimates listed in Table 1, which assume complete and com-
parable helical conformations. Moreover, this effect, along with
its higher helical hydrophobic moment (see Table 1), may even
make aurein 1.2 more prone to partition into the polar/apolar
interfaces of lipid membranes than either citropin 1.1 or macu-
latin 1.1.
In principle, the suggestion that aurein 1.2 may actually be
more prone to partition into membrane polar/apolar interfaces
than either citropin 1.1 or maculatin 1.1, in combination with
effects attributable to differences in the size and net charges of
these peptides, can provide a plausible framework for ratio-
nalizing our experimental observations. Given its larger size and
greater net charge on its polar surface, maculatin 1.1 will be
inherently more disruptive of the structure and organization of
lipid membranes per mol bound than either citropin 1.1 or
aurein 1.2. Although these membrane-disruptive properties will
be attenuated by its overall lower propensity for partitioning
into lipid membranes, the magnitude of the size and charge
differential between maculatin 1.1 and the other peptides (espe-
cially aurein 1.2) is such that size and charge-related effects are
likely to predominate, as long as the differences between the
2799G.W.J. Seto et al. / Biochimica et Biophysica Acta 1768 (2007) 2787–2800partitioning of the peptides are not excessive. However, with
aurein 1.2 and citropin 1.1, the size and charge differential
between the two peptides is considerably smaller and as a result,
effects attributable to the higher membrane partitioning
propensity of aurein 1.2 will probably be more noticeable. We
therefore suggest that these effects are likely manifested by the
greater disruption of model lipid membranes by aurein 1.2 as
noted in these and other biophysical studies, and in the small
differences between the assayed antimicrobial activities of these
two peptides. An evaluation of the relationship between the
partitioning of these peptides into various lipid membranes and
their capacity for disrupting both model and biological mem-
branes is at the focus of our ongoing investigations.
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